当前位置:考试网  > 试卷库  > 职业资格  > 从业资格考试  > 教师资格  > 小学教育学  >  四(2)班小明最近在校表现不好,学习成绩直线下滑,为了解小明在家中的情况,班主任顾老师到小明家家访。在同小明父亲交流情况时,顾老师引用了一句古语:“养不教父之过。”小明的父亲听后很不高兴地说:“顾老师,您这话欠妥,孩子是我生养的,我不送他到学校接受教育,剥夺他受教育的权利,那是我的过错,现在,我把孩子送到学校接受教育,你们教不好,这应是老师的过错,怎么能说是我们做家长的过错呢?”结果,双方未能在教育小明的问题上达成共识。 问题: 结合材料,谈谈你对教师与家长冲突的看法。 试述教师家访的注意事项。
试题预览

四(2)班小明最近在校表现不好,学习成绩直线下滑,为了解小明在家中的情况,班主任顾老师到小明家家访。在同小明父亲交流情况时,顾老师引用了一句古语:“养不教父之过。”小明的父亲听后很不高兴地说:“顾老师,您这话欠妥,孩子是我生养的,我不送他到学校接受教育,剥夺他受教育的权利,那是我的过错,现在,我把孩子送到学校接受教育,你们教不好,这应是老师的过错,怎么能说是我们做家长的过错呢?”结果,双方未能在教育小明的问题上达成共识。

问题:

结合材料,谈谈你对教师与家长冲突的看法。

试述教师家访的注意事项。

查看答案
收藏
纠错
正确答案:

(1)材料中发生家校冲突的原因主要是未达成教育的合力。

首先,家校合作共育的过程中,一些老师发现孩子的问题后只知找家长告状,把责任往家长身上推,做法欠妥,让家长对老师的要求产生抵触情绪。

其次,很多家长片面的认为,家庭只需要把孩子照顾好就可以了,教育问题应该由学校全权负责,缺少与学校的配合观念。造成了家校之间的冲突。

所以在家校相处的过程中,学校和家庭应承担相应的职责,秉承家校共育的理念,促进学生更好的发展。

(2)家访注意事项:

1)提前与家长沟通做好相关准备,

2)明确家访的目的性。

3)在家访过程中注重实效性,与家长沟通中做到尊重、平等。

4)最终形成教育的合力。

答案解析:

暂无解析

你可能感兴趣的试题

马克思关于人的全面发展学说认为实现人的全面发展的唯一方法和根本途径是______。

教育学未成为独立学科前常常同哲学、政治、伦理、宗教等思想混杂在一起。

教师建立良好师生关系的基本要求有哪些?

教育学是研究人的各种属性极其规律的科学。

()的课堂行为指与促进课堂教学目的实现相联系的行为。

热门试题 更多>
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib,a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients,a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman,a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs,which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically,torcetrapib blocks a protein called cholesterol ester transfer protein (CETP),which normally transfers the cholesterol from high-density lipoproteins to low density,plaque-promoting ones.Statins,in contrast,mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired,something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation,it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed,says Moti Kashyap,who directs atherosclerosis research at the VA Medical Center in Long Beach,California.When HDLs excrete cholesterol in the liver,they actually rely on LDLs for part of this process.So inhibiting CETP,which prevents the transfer of cholesterol from HDL to LDL,might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug,called niacin,is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by,for example,introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib,not the whole idea of raising HDL," says Michael Miller,director of preventive cardiology at the University of Maryland Medical Center,Baltimore. Questions 7-13 Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)..Write the correct letter A,B,C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap,it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类: 阅读
练习次数:3次
试题分类: 口语
练习次数:0次
试题分类: 安全保护服务人员
练习次数:0次
扫一扫,手机做题